## BBY: Best Buy Co., Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.98 indicates fundamental undervaluation. Quality metrics strong (ROE 22%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-1.9% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($66.94)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. What retail stores are open Christmas Eve? See hours for Kohl's, TJ Maxx, more**
- Source: USA Today | 20251222T200909 | Neutral | Relevance: 70%
- This article provides a comprehensive list of retail stores that will be open on Christmas Eve 2025, detailing their adjusted hours. It covers various categories from general merchandise to home improvement and pet stores, offering guidance for last-minute shoppers. The article advises checking local store hours as they can vary by location.

**2. How Sluggish Same-Store Sales And Thin Margins At Tractor Supply (TSCO) Have Changed Its Investment Story**
- Source: Simply Wall Street | 20251222T142637 | Neutral | Relevance: 63%
- Tractor Supply (TSCO) is facing pressure from sluggish same-store sales and a low gross margin of 36.4%, indicating customer disengagement and challenges from commoditized inventory and tough competition. While the company maintains quarterly dividends, these issues raise concerns about its investment narrative, suggesting the need for a turnaround in comparable store sales. Despite current pressures, forecasts project significant revenue and earnings growth by 2028, with fair value estimates showing potential upside.

**3. BostInno - An ambitious new healthcare data startup | HubSpot's new fund**
- Source: The Business Journals | 20251220T000924 | Neutral | Relevance: 61%
- This article covers the launch of ScienceIO, a new Boston-based healthcare data startup focusing on fixing healthcare's data problems with a developer-centric approach. It also highlights HubSpot's new $100 million "The CRM Platform Fund" aimed at investing in tech startups that align with its mission to help organizations grow. Additionally, it features other local startup and innovation news, including acquisitions and new board appointments.

**4. USA Financial Formulas Makes New $770,000 Investment in Dollar Tree, Inc. $DLTR**
- Source: MarketBeat | 20251221T132749 | Neutral | Relevance: 60%
- USA Financial Formulas has invested $770,000 in Dollar Tree, Inc., purchasing 8,156 shares in Q3. This new investment comes as Dollar Tree beats quarterly expectations, raises its 2025 sales outlook, and completes a major share buyback. Despite a "Hold" consensus rating and potential liquidity concerns, analysts have increased price targets, and institutional ownership remains high.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $80 | $85 | -6% |
| 2025-11-26 | Truist Securiti | $84 | $79 | +6% |
| 2025-11-26 | Barclays | $81 | $74 | +9% |
| 2025-11-26 | UBS | $96 | $93 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-26 | Truist Securiti | main | Hold |
| 2025-11-26 | Barclays | main | Equal-Weight |
| 2025-11-26 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($1.24M) |
| Sells | 8 ($108.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.9% (-0.5%)
- Vanguard Group Inc: 11.4% (+2.4%)
- State Street Corpora: 6.4% (-2.2%)
- JPMORGAN CHASE & CO: 4.5% (+74.1%)
- Charles Schwab Inves: 3.5% (+3.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.9% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $108M sold (8 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +7%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.98 indicates undervaluation relative to growth. Quality metrics strong (ROE 22%). Analyst sentiment positive (6 raises, avg +7%). Insider selling cluster ($108.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.0B |
| Beta | 1.39 |
| 52W Range | $54.99 - $91.68 |
| Short Interest | 7.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.98 |
| Forward P/E | 10.6 |
| Current P/E | 11.2 |
| YoY Growth | 6.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.1% to -4.0% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.0pp (needs >4.0% for momentum thesis). AM_20 at -3.4% indicates price below own 20MA trend. Underperforming sector by 5.8pp, stock-specific weakness. Below SMA200 (0.99x), long-term trend not supportive. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.97% (CS: 13) | Weak |
| RSI_14 | 36.5 | Neutral |
| MACD Histogram | -0.21 | Bearish |
| vs SMA20 | 0.957x | Below |
| vs SMA50 | 0.922x | Below |
| vs SMA200 | 0.986x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $71.28
- **Stop Loss:** $66.94 (6.1% risk)
- **Target:** $79.96 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 207
- **Position Value:** $14,754.96
- **Portfolio %:** 14.75%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-03-03 (Est: $2.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.31 | $1.40 | +6.7% |
| 2025Q3 | $1.22 | $1.28 | +4.5% |
| 2025Q2 | $1.10 | $1.15 | +5.0% |
| 2025Q1 | $2.41 | $2.58 | +7.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*